Monday, October 3, 2022

Aarogya Swaraj - Ensuring Healthcare for All

DED Due to Diabetes: The Inevitable Duo

Docplexus is one of the world's largest online communities
Hi Renukaprasad A R,
What is your opinion about dry eye disease (DED) due to diabetes?
DED is one of the most prominent pitfalls of diabetes and needs to be managed efficiently. Clinical evidence has demonstrated a 54% prevalence of symptomatic and asymptomatic DED in people with diabetes. Its incidence is directly proportional to glycated hemoglobin (HbA1c) levels and is more common in women than in men.
Watch this Specialty Spotlight to understand the relationship between DED and diabetes and DED treatment strategies!

Highlights:
  • DED and diabetes
  • Etiology of DED in diabetes
  • Prevalence of DED in diabetes
  • Clinical characteristics of DED in diabetes
  • Management of DED in diabetes
Click to Watch
Add docplexus to primary
If you don't want to receive these emails in the future, please unsubscribe.
 
Shadow

Sunday, October 2, 2022

Clinical Utility of SMBG in Diabetes Management

Docplexus is one of the world's largest online communities
Hi Renukaprasad A R,
6.7 million deaths in 2021 are attributed to diabetes (worldwide). Currently, 537 million adults live with diabetes, which is estimated to rise to 643 million by 2030.1
One of the effective strategies to manage type 2 diabetes mellitus (T2DM) is early and aggressive treatment.1 Self-monitoring of blood glucose (SMBG) plays a pivotal role in structured T2DM management by providing updates on current glycemic status, thus implementing appropriate measures for efficient glycemic control.2
Check out this exclusive Journal Watch, which summarizes two studies demonstrating the relevance of SMBG in the early and effective treatment of T2DM.

References
  1. IDF Diabetes Atlas 10th edition (2021). Available at https://diabetesatlas.org/
  2. Parkin CG. Diabetes research and clinical practice. 2012 Jul 1;97(1):6-15.
Click to Read
Add docplexus to primary
If you don't want to receive these emails in the future, please unsubscribe.
 
Shadow

The Last Week of Our 9th Anniversary Celebration is Here!

Saturday, October 1, 2022

Advanced Therapeutics for Ocular Diseases